AAL

25 Worst Stocks to Own in January

Potential policy changes could add additional pressure to the vaccine stock

Deputy Editor
Dec 30, 2024 at 12:21 PM
facebook X logo linkedin


As President-elect Donald Trump prepares for his inauguration, his administration is gearing up to roll out significant policy shifts. Among these moves is the selection of Robert F. Kennedy Jr. to lead the Department of Health and Human Services -- a decision that's already putting pressure on vaccine stocks. For cautious investors, this could be a signal to steer clear of Pfizer Inc (NYSE:PFE), a stock with a history of underperforming in January.

According to data from Schaeffer's Senior Quantitative Analyst Rocky White, PFE averaged a January loss of 4.6% over the past 10 years, and finished the month in the red eight of those times. In fact, the last time Pfizer stock was higher for the month of January was in 2018. A comparable move from the security's current perch of $26.39 would place it near the $25 level.

Worst of 2024 December 302024

The equity is pulling back slightly today, though it remains well above its Nov. 15 dip to $24.48 -- its lowest mark since January 2013. Shares are down 8.2% in 2024, though they're pacing for a small December gain to snap a four-month losing streak. 

PFE Chart December 302024

Should this historical trend play out once again, it could force options traders to change their optimistic tune -- a move that could weigh on PFE. This is per the security's Schaeffer's put/call open interest ratio (SOIR) of 0.55 that sits in the 1st percentile of annual readings, pointing towards a penchant for calls amongst short-term premium players. 

Options look to be an attractive route to go when weighing in on the Pfizer stock, according to its Schaeffer's Volatility Index (SVI) of 20% that ranks in the 11th percentile of the last 12 months. What's more, the security's Schaeffer's Volatility Scorecard (SVS) sits at a relatively low 30 out of 100, making it a prime selling candidate for these short-term bulls.  

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.